You searched for "complaints"

1456 results found

Fight for Sight to maximise impact by funding solutions-focused research in priority eye conditions

Fight for Sight aims to stop sight loss by funding pioneering research. Rod McNeil takes a look at the Primer Fellowship Awards programme, which provides funding for up to £60,000 for individuals to undertake vision-related research for one year. Among...

Ciclosporin and dry eye

Dry eye has an estimated prevalence of between 5 and 50% worldwide and has physical, psychological and socioeconomic consequences for the human population [1]. Loss of tear film homeostasis with associated ocular surface inflammation causes symptoms ranging from ‘tired’ eyes...

Implementing technology to improve global eye health

Technological innovation is providing new solutions to transform global eye health [1–5]. In particular, research towards the development of artificial intelligence (AI) tools in ophthalmology has gained pace in recent years. However, there has been little research relating to its...

Retina Subspecialty Day highlights from the RCOphth 2026 Annual Congress

Implementation of biosimilars in NHS retinal services A NHS England (NHSE) perspective Luke Nicholson (Moorfields Eye Hospital) explained that the NHSE perspective overall is structured on best value medicine for the patient and system, accounting for a finite budget and...

Anatomical Three-dimensional Orbital ModelS (ATOMS) in Ophthalmology Education

Our educational aim is to provide a simple blended learning solution to ophthalmology trainees centered around Anatomical Three-dimensional Orbital ModelS (ATOMS) to help teach orbital anatomy and make it simple to learn.

The College of Optometrists publishes updated Clinical Governance Guidance to support quality improvement and excellence in optometry

The College of Optometrists has launched its updated Clinical Governance Guidance to provide members with a robust framework that aligns with the healthcare landscape and primary care optometry workplace practices of today - and into the future. The guidance will...

Green Charter inspires the Optical Community

Green Charter – the optical community’s clear pathway for a sustainable future – attracted great interest at 100% Optical, with businesses keen to learn more about specific guidance. Launched by Opticare Innovations, the commercial arm of the OSA, the five...

Glaucoma medications and ocular surface disease

This literature review examined ocular surface disease (OSD) associated with glaucoma medication. The authors examined the prevalence of features and management guidelines glaucoma medication associated OSD. Fifty-eight articles published within the past five years are included in this review and...

Oertli Instrumente AG achieves milestone with FDA 510(k) clearance for Faros surgical system

Oertli Instrumente AG, a leader in innovative surgical solutions for ophthalmology, is proud to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance for the worldwide established Faros anterior cataract surgery system. This milestone underscores Oertli's global reach and...

Introducing the Surgitrac Information Hub: A New Resource for Ophthalmic Professionals

Finding reliable, practical information in ophthalmology should not feel difficult. That is why Surgitrac has launched its brand-new Information Hub, a dedicated online resource designed to support surgeons, theatre teams, nurses and procurement professionals with trusted educational content and essential...

Vitreoretinal Disease: Diagnosis, Management and Clinical Pearls (second edition)

A comprehensive, well-illustrated and highly informative resource providing excellent descriptions of vitreoretinal diseases, their presentation, diagnosis and management. The 40 chapters are grouped into four sections, namely: the Anatomy and Physiology of the vitreous, retina, choroid and retinal pigment epithelium;...

Exploring the potential of neurodegenerative disease screening within age-related eye disease research

The authors recruited healthy controls aged between 60 and 75-years-old, previously enrolled into a registry as patients following cataract surgery without age-related macular degeneration (AMD). Exclusion criteria included dense cataract, retinal disease, ocular inflammatory disease, moderate glaucoma, optic neuropathy, cancer,...